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POTENTIATION OF ITCH AND FLARE RESPONSES IN HUMAN SKIN BY 
PROSTAGLANDINS E2 AND H2 AND A PROSTAGLANDIN 
ENDOPEROXIDE ANALOG 
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The itch and erythematous responses induced by intradermal injection of prostaglandin 
E2 (PGE2), the unstable prostaglandin endoperoxide PGH2 (tl / 2 - 5 min at 37°C) and the 
stable endoperoxide ·analog (158)-hydroxy-9a, lla-(epoxymethano)prosta-5,13-dienoic acid 
(EPA) were studied in volunteers. The compounds were given alone or in,combination with 
histamine. All the compounds produced flare reaction in the skin; the order of potency was 
PGE2 > PGH2 > EPA. PGE2 and PGH2 evoked a sensation of itch in about half of the 
subjects whereas the same doses of EPA gave no itch response. In combination with 
histamine all compounds elicited itch of longer duration and flare of larger area than could 
be accounted for by simple additive effects of any released histamine. The results indicate 
that the PGs and PG intermediates formed in skin may potentiate the pruritogenic and 
flare-inducing effects of inflammagens in man. 
When prostaglandin E2 (PGE2) is injected intra-
dermally in man there is a two-phase vascular 
response with an initial, rapidly developing, 
bright-red erythema similar to the histamine-elic-
ited flare, followed by a smaller dusky red and 
more well-delimited erythema [1-3]. During the 
initial phase some subjects experience itch at the 
injection site [ 4-6] and during the second phase 
the erythematous area is hyperalgesic [1,2,5]. The 
initial flare and the itch response are reduced by 
pretreatment with chlorcyclizine, a histamine (H, 
receptor) antagonist, indicating that at least part 
of the PGE2 elicited reactions are mediated by 
histamine released from the skin mast cells [6]. It 
was also demonstrated that PGE2 , when adminis-
tered in combination with histamine, potentiates 
the histamine-elicited itch and flare , i.e., the 
responses are stronger than might be expected 
from a mere summation of the histamine and 
PGE2 effects [6]. 
Prostaglandin biosynthesis proceeds through 
short-lived endoperoxide intermediates [7]. In 
some experimental systems the PG endoperoxides 
are considerably more potent than PGE2 and 
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PGF 2o [8). Accordingly it has been suggested that 
a major part of the biological activity generated 
on PG formation might be due to the action of the 
PG endoperoxides. However, because the endoper-
oxides are labile, their biological effects are diffi-
cult to study. The recent development of stable 
PG endoperoxide analogs has made studies of the 
pharmacology of the endoperoxides more feasible 
[9,10]. 
In the present investigation the short-lived en-
doperoxide PGH2 and a stable epoxy-methano an-
alog of PGH2 were compared with PGE2 for pruri-
togenic and vascular actions on intradermal injec-
tion and for ability to potentiate such responses 
when elicited by histamine. 
MATERIALS AND METHODS 
Healthy volunteers aged 18-40 years participated in 
this investigation. The technique for studying itch and 
flare responses has been described previously [6 ,11]. 
The subjects were injected intracutaneously on the 
lateral aspect of the upper arm with 0.02 ml of the 
solutions to be studied . The duration of the itch re-
sponse was recorded. The flare reaction was outlined 
on the skin after 3, 5, 20 , and in some cases 60 min. 
The areas were traced on a transparent plastic film 
and measured planimetrically. 
PGH. was synthetized as described previously [7] , 
PGE. was kindly suppli ed by Dr. J. Pike, the Upjohn 
Co, Kalamazoo, Michigan , U .S.A. The endoperoxide 
analog (EPA) used was synthetized [9] and kindly 
supplied by Dr. G. L. Bundy, the Upjohn Co , Kalama-
zoo , Michigan, U.S.A. (Fig 1). The preparations were 
stored at -20°C in 95% ethanol (1 mg/ml) until use. 
On the day of the experiment fresh dilutions were 
made in physiologic saline containing 10% (v/v) Soren-
sen phosphate buffer (Na2HPO,+KH2PO, , 67 mM), pH 
7.4. The PGH2 dilutions were made immediately before 
injection. Histamine hydrochloride was dissolved in 
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the buffered saline solution. In control experiments 
the amounts of ethanol used were found to have no 
effect on responses elicited by histamine. 
RESULTS 
PGE2 , PGH2, and EPA, all produced an initial 
flare reaction in the skin although EPA was less 
potent than the other 2 compounds. Figures 2-4 
show the time courses of the erythematous re-
sponses, when 0.1 1-Lg of the compounds were 
injected; histamine was included for comparison. 
The initial, bright-red flare elicited by PGE2 and 
PGH2 gradually subsided and was replaced by a 
more dusky red erythema which persisted for 
hours, while the weak reaction elicited by EPA 
disappeared in 20 min. 
PGE2 (0.1 /-Lg) evoked a sensation of itch in 6 of 
11 subjects . The itch duration was within the 
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FIG 1. Structures of prostaglandins and endoperoxide 
analog. 
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FIG 2. Time course of flare reactions induced by 
prostaglandin E2 and histamine alone and in combina-
tion (mean ± SE, n = 11). 
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range of that evoked by 0.02 and 0.067 1-Lg of 
histamine. PGH2 (0.1 /-Lg) produced itch in 3 of 7 
subjects. The duration was shorter than observed 
with the lowest dose of histamine (0.02 fLg). EPA 
(0 .1 /-Lg) gave no itch response in the subjects 
studied. In a preliminary series of experiments, 
where 0.5 1-Lg of EPA was given to 7 subjects, only 
1 felt a slight itch for 27 sec. 
When the PGs and histamine were mixed (0.1 
1-Lg of PG + 0.067 1-Lg of histamine) and injected it 
was noted that the flare usually was larger than 
that elicited by histamine (0.2 /-Lg) . Similarly, the 
itch response increased markedly (Table). 
To assess whether the effect of combining PGs 
with histamine was due to potentiation or sum-
mation of the pharmacological effects of the 2 
agonists, the responses obtained by PGs alone 
and in combination with histamine, respectively, 
were intrapolated in the dose response curves for 
histamine. This operation gave "histamine equiv-
alents," i.e., the amounts of histamine that would 
be required to give responses equivalent to those 
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FIG 3. Time course of flare reactions induced by 
prostaglandin H2 and histamine alone and in combina-
tion (mean± SE, n = 7). 
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FIG 4. Time course of flare reactions ind~ced by 
endoperoxide analog and histamine alone and m com-
bination (mean± SE, n = 12) . 
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evoked by PGs alone or when combined with 
histamine. The results are summarized in Fig 5. 
It appears that the combination yielded responses 
that cannot be explained by a mere summation of 
effects. The itch responses seemed to be more 
enhanced than the vascular reactions. The poten-
tiating effects of PGE2 (n = 11) and EPA (n = 12) 
were statistically significant (p < 0.01) according 
to the sign test of Dixon and Massey [12]. In the 
experiments with PGH2 the potentiating effect 
was seen in 6 of7 subjects (p > 0.05). 
Pruritogenic responses evoked by PGE2 , PGH2 , EPA 
alone and in combination with histamine (Hi) 
No. of Itch dura-
Series Compound ( IJl!) subjects tion (sec) perceiv- mean ± 
mg itch SEM" 
I (n = 11) PGE2 0.1 6 27 ± 10 
Hi 0.02 4 14 ± 6 
Hi 0.067 9 46 ± 13 
Hi 0.2 11 65 ± 11 
Hi 0.67 11 97 ± 17 
PGE2 0.1 +Hi 0.067 11 111 ± 22 
II (n = 7) PGH2 0.1 3 15 ± 7 
Hi 0.02 5 66 ± 26 
Hi 0.067 6 108 ± 60b 
Hi 0.2 6 169 ± 73 
PGH2 0.1 +Hi 0.067 7 277 ± 131 
III (n = 12) EPA 0.1 0 0 
Hi 0.02 4 9±5 
Hi 0.067 10 25 ± 6 
Hi 0.2 12 53 ± 11 
Hi 0.67 12 87 ± 15 
EPA 0.1 + Hi 0.067 12 78 ± 15 
a SEM = standard error of the mean 
6 One subject > 5 min 
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FIG 5. Itch and flare induced by 0.1/Lg of prostaglan-
dins E 2 and H2 and endoperoxide analog alone and in 
combination with 0.067 !Lg of histamine. Mean re-
sponses from the experiments illustrated in Fig 2-4 are 
expressed as "histamine equivalents," i.e., the amounts 
of histamine that would be required to elicit the same 
itch and flare responses. The flare reactions were 
measured after 5 min. 
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DISCUSSION 
In this study, PGE2 was found to be more potent 
than PGH2 and EPA in producing itch and flare 
reactions in human skin. Comparisons ofthe phar-
macological activities of PGE2 and PGH2 in other 
biological systems have shown that the PG endo-
peroxides are more active than PGE2 and PGF2a 
on some airway and vascular smooth muscle prep-
arations and equipotent with PGE2 on gastrointes-
tinal smooth muscle tissues [8,13]. In view of the 
short half-life of the PG endoperoxides, about 5 
min in an aqueous medium at 37o C [7] , responses 
produced by the endoperoxides and not by their 
degradation products, e.g., PGE2, are more likely 
to be observed the closer to the target cells the PG 
endoperoxides are administered. Although the 
compounds used in this study were injected intra-
dermally, it can still be argued that the dermal 
reactions observed on injection of PGH2 reflected 
the production of PGE2 rather than the action of 
PGH2 per se. 
The development of stable PG endoperoxide 
analogs has offered a way out of the dilemma 
with studies of the pharmacological actions of the 
short-lived PG endoperoxides. Among such com-
pounds synthetized are the epoxy-methano ana-
logs of PGH2 [9]. In these analogs a methylene 
group is substituted for 1 of the 2 peroxide oxygens 
to give cyclic ethers , i .e. , 9a,ll a -(epoxymethano) 
or lla,9a-(epoxymethano) derivatives. Both ana-
logs are potent aggregators of human platelets 
and contractors of rabbit aorta strips, the 9a,lla-
(epoxymethano) derivative ("EPA") somewhat less 
active than the lla,9a-(epoxymethano) analog 
[14]. The aggregating potency of EPA was about 
half that of PGG2 whereas EPA was almost four 
times more active than PGH2 in eliciting contrac-
tions of the isolated rabbit aorta [14]. 
In the present investigation, EPA caused a 
weak flare reaction and no sensation of itch when 
injected alone in human skin. Indeed, if injection 
of EPA reflects the action of the PG endoperoxides 
our results suggest that PGH2 has little flare and 
itch evoking actions per se. With regard to the 
flare reaction this is not surprising in view of the 
vasoconstrictor nawre of the PG endoperoxides 
[8 ,13]. Furthermore, it is possible that the weak 
flare reaction observed on injection of PGH2 or 
EPA was due to histamine release in analogy 
with the findings for PGE2 [6]. 
PGE2 , PGH2 , and EPA augmented the hista-
mine-induced itch and flare reactions to levels 
that were significantly higher than expected from 
the algebraic sum of the responses to each agent 
acting alone. Although EPA per se had very weak 
effects, it caused the same degree of potentiation 
as PGE2 • By adding EPA, or PGE2 , to the hista-
mine before injection, the flare increased to a size 
that would require about 3 times as much hista-
mine, if it were produced by histamine alone. It is 
of interest to note that the itch responses seemed 
to be more enhanced than the flare reactions . 
PGE2 has previously been shown to enhance 
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many biological responses, e.g., smooth muscle 
contraction [15,16], pain [5], itch [6,17,18], and 
inflammation· [19,20]. The mode of action involved 
remains unclear; PG-induced changes in tissue 
Ca++.binding has been suggested to account for 
the phenomenon [15]. The present data indicate 
that generation not only of the classical PGs but 
also of their intermediates, the PG endoperoxides, 
may have profound effects on the tissue response 
to a variety of stimuli. In addition, it has been 
reported that PGG2 and PGH2 potentiate the oe-
dema of inflammation [21]. 
PGs have been reported to sensitize pain recep-
tors to mechanical and chemical stimulation 
[5,19]. Our data indicate that PGs and PG endo-
peroxides may also enhance the actions of pruritic 
agents . The analgetic effect of nonsteroidal antiin-
flammatory drugs, such as aspirin, has been at-
tributed to their inhibiting action on PG biosyn-
thesis [19]. By and large, however, the clinical 
impression is that salicylates do not alleviate 
pruritic conditions. Whether this reflects that PGs 
are no major mediators of pruritogenic disorders, 
the complexity of the involvement of PGs in such 
disorders (mediator vs modulator roles) or that 
the salicylates have effects in addition to the 
inhibition of PG biosynthesis remains to be ascer-
tained. 
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